U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07098780) titled 'Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery' on July 08.
Brief Summary: The goal of this clinical trial is to learn if tranexamic acid (TXA) helps reduce bleeding during bariatric surgery, such as laparoscopic sleeve gastrectomy (LSG) and mini gastric bypass (MGB). It will also look at how safe TXA is for people undergoing these procedures. The main questions it aims to answer are:
Does TXA reduce the amount of blood loss during bariatric surgery? Are there any side effects or complications in patients who receive TXA? Researchers will compare TXA to standard care (no TXA) to see if it is effective in...